ASSESSMENT OF AWARENESS LEVEL OF OWN DISEASE IN PATIENTS WITH STABLE ARTERIAL HYPERTENSION

ASSESSMENT OF AWARENESS LEVEL OF OWN DISEASE IN PATIENTS WITH STABLE ARTERIAL HYPERTENSION

Show other versions (1)

Arterial hypertension (AH) is the most frequent risk factor of cardiovascular diseases and related mortality in all developed countries. Altough therapy with antihypertensive drugs significantly reduces this risk, patients with stable mild hypertension have poor compliance with the treatment. The re...

Full description

Bibliographic Details
Main Authors:	G. F. Andreeva, V. M. Gorbunov, S. Y. Martsevich
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-12-01
Series:	Рациональная фармакотерапия в кардиологии
Online Access:	https://www.rpcardio.online/jour/article/view/336

Similar Items

ASSESSMENT OF AWARENESS LEVEL OF OWN DISEASE IN PATIENTS WITH STABLE ARTERIAL HYPERTENSION
by: G. F. Andreeva, et al.
Published: (2015-12-01)

ASSESSMENT OF INFLUENCE OF BETAGISTIN IN COMBINATION WITH ANTIHYPERTENSIVE DRUGS ON QUALITY OF LIFE AND NEUROLOGICAL STATUS OF PATIENTS WITH STABLE ARTERIAL HYPERTENSION AND DIZZINESS
by: G. V. Andreeva, et al.
Published: (2015-12-01)

ASSESSMENT OF INFLUENCE OF BETAGISTIN IN COMBINATION WITH ANTIHYPERTENSIVE DRUGS ON QUALITY OF LIFE AND NEUROLOGICAL STATUS OF PATIENTS WITH STABLE ARTERIAL HYPERTENSION AND DIZZINESS
by: G. V. Andreeva, et al.
Published: (2015-12-01)

Influence of betahistidine dihydrochloride and antihypertensive medications on quality of life in patients with stable arterial hypertension and vertigo
by: G. F. Andreeva, et al.
Published: (2005-06-01)

Influence of betahistine dihydrochloride and antihypertensive medication combination on neurological status and quality of life in patients with stable arterial hypertension and vertigo
by: G. F. Andreeva, et al.
Published: (2006-08-01)

EFFECT OF LISINOPRIL AND ENALAPRIL ON QUALITY OF LIFE AND BLOOD PRESSURE DAILY PROFILE IN PATIENTS WITH STABLE ARTERIAL HYPERTENSION.
by: G. F. Andreeva, et al.
Published: (2016-01-01)

Comparison of the effect of treatment with the main groups of antihypertensive drugs on the quality of life in patients with stable arterial hypertension
by: G. F Andreeva, et al.
Published: (2017-06-01)

Nifedipine-retard alone and incombination with metoprolol: comparative efficacy andsafety in patients with arterial hypertension
by: O Yu Isaikina, et al.
Published: (2003-12-01)

SPIRAPRIL EFFECTS ON OFFICE AND AMBULATORY BLOOD PRESSURE LEVELS AND THEIR DIFFERENCE IN PATIENTS WITH ARTERIAL HYPERTENSION
by: V. M. Gorbunov, et al.
Published: (2009-02-01)

Main Factors Related with the White Coat Effect Level in Patients with Arterial Hypertension and Bronchial Asthma
by: G. F. Andreeva, et al.
Published: (2021-05-01)

EFFECT OF ANTIHYPERTENSIVE DRUGS ON QUALITY OF LIFE IN PATIENTS WITH ARTERIAL HYPERTENSION
by: G. F. Andreeva, et al.
Published: (2016-01-01)

EFFECT OF ANTIHYPERTENSIVE DRUGS ON QUALITY OF LIFE IN PATIENTS WITH ARTERIAL HYPERTENSION
by: G. F. Andreeva, et al.
Published: (2016-01-01)

Cardiac risk stratification in stable coronary artery disease
by: S. N. Tolpygina, et al.
Published: (2020-05-01)

Comparative analysis of several methods for blood pressure measurement in the morning in patients with arterial hypertension
by: G. F. Andreeva, et al.
Published: (2018-12-01)

Masked inefficacy of arterial hypertension treatment: prevalence and predictors
by: M. I. Smirnova, et al.
Published: (2011-12-01)

Assessment of the Quality of Drug Therapy in Patients with Stable Coronary Artery Disease in the Second Stage of the ALIGN Study
by: E. D. Zharkova, et al.
Published: (2022-07-01)

Treatment Adherence to Drug Therapyin Patients with Stable Coronary Artery Disease During the COVID-19 Pandemic
by: S. Y. Martsevich, et al.
Published: (2021-03-01)

Cardiovascular risk stratification in stable coronary artery disease based on prognostic scores and models
by: S. N. Tolpygina, et al.
Published: (2020-07-01)

Features of zofenopril and enalapril in patients with stable ischemic heart disease in combination with arterial hypertension
by: A. G Evdokimova, et al.
Published: (2016-06-01)

Contrast-associated acute kidney injury in patients with arterial hypertension and stable coronary artery disease
by: Olga Iu. Mironova, et al.
Published: (2020-10-01)

ONCE AGAIN ABOUT BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION. WHAT SHOULD DOCTOR RECOMMEND TO THE PATIENT?
by: S. Y. Martsevich
Published: (2016-01-01)

ONCE AGAIN ABOUT BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION. WHAT SHOULD DOCTOR RECOMMEND TO THE PATIENT?
by: S. Y. Martsevich
Published: (2016-01-01)

ACE inhibitor spirapril effects on circadian blood pressure profile, quality of life, and psychological status in patients with Stage I-II arterial hypertension
by: V. M. Gorbunov, et al.
Published: (2008-12-01)

RECENT EUROPEAN GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION (2007): WHAT IS NEW IN APPROACH TO CHOICE OF DRUG?
by: S. Y. Martsevich
Published: (2015-12-01)

RECENT EUROPEAN GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION (2007): WHAT IS NEW IN APPROACH TO CHOICE OF DRUG?
by: S. Y. Martsevich
Published: (2015-12-01)

MicroRNA level in patients with stable coronary artery disease with borderline coronary artery stenosis
by: D. A. Yakhontov, et al.
Published: (2022-11-01)

INFLUENCE OF ANTIHYPERTENSIVE DRUGS ON ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION
by: N. V. Egorkina, et al.
Published: (2016-01-01)

INFLUENCE OF ANTIHYPERTENSIVE DRUGS ON ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION
by: N. V. Egorkina, et al.
Published: (2016-01-01)

White coat effect in patients with hypertension
by: G. F. Andreeva, et al.
Published: (2023-11-01)

PATHOGENETIC DIFFERENCES BETWEEN LABILE AND STABLE ARTERIAL HYPERTENSION
by: E. M. Evsikov, et al.
Published: (2011-02-01)

ROLE OF BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION TREATMENT. WHAT DO EVIDENCE BASED MEDICINE DATA SHOW?
by: S. Y. Martsevich
Published: (2016-01-01)

NEWS FROM THE ANNUAL CONGRESS ON ARTERIAL HYPERTENSION (BERLIN, JUNE 2008): CHANGES IN THE TREATMENT STRATEGY ARE PLANNING
by: S. Y. Martsevich
Published: (2016-01-01)

NEWS FROM THE ANNUAL CONGRESS ON ARTERIAL HYPERTENSION (BERLIN, JUNE 2008): CHANGES IN THE TREATMENT STRATEGY ARE PLANNING
by: S. Y. Martsevich
Published: (2016-01-01)

Does Arterial Hypertension Affect Plasma Levels of Matrix Metalloproteinases and Their Tissue Inhibitors in Patients with Stable Coronary Artery Disease? A Preliminary Study
by: Wiktor Kuliczkowski, et al.
Published: (2019-01-01)

Significance of troponin levels in patients with stable coronary artery disease
by: T. De, et al.
Published: (2014-11-01)

AN ASSESSMENT OF THE LEVEL OF HIV/AIDS AWARENESS AND VULNERABILITY IN STATE-OWNED TERTIARY INSTITUTIONS OF BAUCHI NIGERIA
by: Sani Babaji
Published: (2022-12-01)

Modern management of arterial hypertension: has the position of beta-adrenoblockers changed
by: S. Yu. Martsevich
Published: (2007-08-01)

Zofenopril in the treatment of patients with arterial hypertension and stable coronary heart disease: effects on oxidative stress and flowdependent vasodilatation
by: F. T. Ageev, et al.
Published: (2011-06-01)

COMPARATIVE EVALUATION OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE
by: S. N. Tolpygina, et al.
Published: (2015-12-01)

COMPARATIVE EVALUATION OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE
by: S. N. Tolpygina, et al.
Published: (2015-12-01)